Quent Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Quent Capital's PFE Position: Q2 2026 in Review
Quent Capital reduced its Pfizer (PFE) stake by 2.3% in Q2 2026, selling an estimated $9.52K and leaving 15,327 shares worth $369K. The position accounts for 0.02% of the portfolio, ranked #290.
Quent Capital first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $921K in Q4 2022. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Quent Capital held 15,327 shares of Pfizer worth $369K as of Q2 2026.
- Quent Capital sold 364 Pfizer shares in Q2 2026, an estimated $9.52K.
- Pfizer made up 0.02% of Quent Capital's portfolio in Q2 2026, its #290 holding.
- Quent Capital first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Quent Capital's Pfizer position peaked at $921K in Q4 2022.
- 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.